Published date: 2025-08-30 19:15:49
CAS number: 347396-82-1
Name: Ranibizumab (anti-VEGF)
Price:
$Inquiry/500mg
$Inquiry/1g
$Inquiry/2g
$Inquiry/5g
Purity: 99.0%
Stocking period: Inquiry
Stock: In Stock
Detail Product Information:
Ranibizumab is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. Ranibizumab binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A). Ranibizumab, which lacks an Fc region, has a molecular weight of approximately 48 kilodaltons and is produced by CHO expression system.
Ranibizumab is supplied at a concentration of 20 mg/mL as a sterile, colorless to pale yellow solution, which contains 10 mM histidine HCl, 10% α,α-trehalose dihydrate, 0.01% polysorbate 20, pH 5.5.
Name: Shanghai Topwell Pharma Co., Ltd.
Chemsrc Level: Unverified
Product #: 9
Tel: +86-02158180488
Address: Room 315, Building 3, No. 1666, Xinyang Highway, Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone
Area: China
Contact: Bruce
Contact Phone #: +86-21-58180488
Email: sales@topwellpharma.com
Website: http://www.topwellpharma.com
Major Market: Europe and America
Annual Trade Volume:
Foreign Trade % of Salers:
Major partners:
Detail
introduction:
Shanghai Topwell Pharma Co., Ltd. is specialized in research, development, custom manufacturing and sales of Pharmaceutical Intermediates, APIs, Pharmaceutical Excipients, Health & Nutritional Ingredients, Polypeptides and Antibodies, etc..
Topwell has a professional R&D team. We have built close cooperative relationships with many research institutes and universities in China. In addition, we have very close cooperation relationships with many Chinese pharmaceutical factories.
Topwell aims to become a global leader in pharmaceutical & chemical industry.
Name: Shanghai Nianxing Industrial Co., Ltd
Area: China
Price:
$Inquiry/500mg
$Inquiry/1g
$Inquiry/2g
$Inquiry/5g
Contact: Yang
Product Detail: Ranibizumab (anti-VEGF)
Get all suppliers by the below link:
2024-07-15 Ranibizumab (anti-VEGF)
2022-10-20 Ranibizumab (solution for R&D only)
2023-02-09 Ranibizumab (anti-VEGF)
2026-03-09 Ranibizumab (anti-VEGF)
2022-09-23 Ranibizumab (anti-VEGF)
Get all price from the following link: